Search

Your search keyword '"Zalupski, Mark M."' showing total 148 results
Start Over Author "Zalupski, Mark M." Database Unpaywall
148 results on '"Zalupski, Mark M."'

2. Genomics driven precision oncology in advanced biliary tract cancer improves survival

Author

Kumar-Sinha, Chandan, primary, Vats, Pankaj, additional, Tran, Nguyen, additional, Robinson, Dan R., additional, Gunchick, Valerie, additional, Wu, Yi-Mi, additional, Cao, Xuhong, additional, Ning, Yu, additional, Wang, Rui, additional, Rabban, Erica, additional, Bell, Janice, additional, Shankar, Sunita, additional, Mannan, Rahul, additional, Zhang, Yuping, additional, Zalupski, Mark M., additional, Chinnaiyan, Arul M., additional, and Sahai, Vaibhav, additional

Published
2023
Full Text
View/download PDF

3. Supplementary Table S2 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

4. Supplementary Table S4 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

5. Supplementary Table S1 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

6. Data from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Figure S3 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Table S3 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Table S1 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Table S4 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure S2 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Figure S3 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Table S2 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure S2 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure S1 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

16. Data from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure S1 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Table S3 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., primary, Wuchu, Fulei, primary, Zhen, David B., primary, Kumar-Sinha, Chandan, primary, Crysler, Oxana, primary, Hsiehchen, David, primary, Enzler, Thomas, primary, Dippman, Dominique, primary, Gunchick, Valerie, primary, Achreja, Abhinav, primary, Animasahun, Olamide, primary, Choppara, Srinadh, primary, Nenwani, Minal, primary, Chinnaiyan, Arul M., primary, Nagrath, Deepak, primary, Zalupski, Mark M., primary, and Sahai, Vaibhav, primary

Published
2023
Full Text
View/download PDF

19. Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)

Author

Mohan, Arathi, primary, Griffith, Kent A., additional, Wuchu, Fulei, additional, Zhen, David B., additional, Kumar-Sinha, Chandan, additional, Crysler, Oxana, additional, Hsiehchen, David, additional, Enzler, Thomas, additional, Dippman, Dominique, additional, Gunchick, Valerie, additional, Achreja, Abhinav, additional, Animasahun, Olamide, additional, Choppara, Srinadh, additional, Nenwani, Minal, additional, Chinnaiyan, Arul M., additional, Nagrath, Deepak, additional, Zalupski, Mark M., additional, and Sahai, Vaibhav, additional

Published
2023
Full Text
View/download PDF

20. Abstract CT226: Crizotinib (C) in patients (pts) with solid tumors with MET amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Author

Mileham, Kathryn F., primary, Rothe, Michael, additional, Mangat, Pam K., additional, Garrett-Mayer, Elizabeth, additional, Duvivier, Herbert L., additional, Calfa, Carmen J., additional, Dul, Carrie L., additional, Marr, Alissa S., additional, Ahn, Eugene R., additional, Behl, Deepti, additional, Hall, Michael J., additional, Mehmi, Inderjit, additional, Gaba, Anu, additional, Leidner, Rom, additional, Zalupski, Mark M., additional, Grantham, Gina N., additional, Gregory, Abigail, additional, Halabi, Susan, additional, and Schilsky, Richard L., additional

Published
2023
Full Text
View/download PDF

22. Data from Identification of Targetable FGFR Gene Fusions in Diverse Cancers

Author

Wu, Yi-Mi, primary, Su, Fengyun, primary, Kalyana-Sundaram, Shanker, primary, Khazanov, Nickolay, primary, Ateeq, Bushra, primary, Cao, Xuhong, primary, Lonigro, Robert J., primary, Vats, Pankaj, primary, Wang, Rui, primary, Lin, Su-Fang, primary, Cheng, Ann-Joy, primary, Kunju, Lakshmi P., primary, Siddiqui, Javed, primary, Tomlins, Scott A., primary, Wyngaard, Peter, primary, Sadis, Seth, primary, Roychowdhury, Sameek, primary, Hussain, Maha H., primary, Feng, Felix Y., primary, Zalupski, Mark M., primary, Talpaz, Moshe, primary, Pienta, Kenneth J., primary, Rhodes, Daniel R., primary, Robinson, Dan R., primary, and Chinnaiyan, Arul M., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figures from Identification of Targetable FGFR Gene Fusions in Diverse Cancers

Author

Wu, Yi-Mi, primary, Su, Fengyun, primary, Kalyana-Sundaram, Shanker, primary, Khazanov, Nickolay, primary, Ateeq, Bushra, primary, Cao, Xuhong, primary, Lonigro, Robert J., primary, Vats, Pankaj, primary, Wang, Rui, primary, Lin, Su-Fang, primary, Cheng, Ann-Joy, primary, Kunju, Lakshmi P., primary, Siddiqui, Javed, primary, Tomlins, Scott A., primary, Wyngaard, Peter, primary, Sadis, Seth, primary, Roychowdhury, Sameek, primary, Hussain, Maha H., primary, Feng, Felix Y., primary, Zalupski, Mark M., primary, Talpaz, Moshe, primary, Pienta, Kenneth J., primary, Rhodes, Daniel R., primary, Robinson, Dan R., primary, and Chinnaiyan, Arul M., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Tables from Identification of Targetable FGFR Gene Fusions in Diverse Cancers

Author

Wu, Yi-Mi, primary, Su, Fengyun, primary, Kalyana-Sundaram, Shanker, primary, Khazanov, Nickolay, primary, Ateeq, Bushra, primary, Cao, Xuhong, primary, Lonigro, Robert J., primary, Vats, Pankaj, primary, Wang, Rui, primary, Lin, Su-Fang, primary, Cheng, Ann-Joy, primary, Kunju, Lakshmi P., primary, Siddiqui, Javed, primary, Tomlins, Scott A., primary, Wyngaard, Peter, primary, Sadis, Seth, primary, Roychowdhury, Sameek, primary, Hussain, Maha H., primary, Feng, Felix Y., primary, Zalupski, Mark M., primary, Talpaz, Moshe, primary, Pienta, Kenneth J., primary, Rhodes, Daniel R., primary, Robinson, Dan R., primary, and Chinnaiyan, Arul M., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Tables from Identification of Targetable FGFR Gene Fusions in Diverse Cancers

Author

Wu, Yi-Mi, primary, Su, Fengyun, primary, Kalyana-Sundaram, Shanker, primary, Khazanov, Nickolay, primary, Ateeq, Bushra, primary, Cao, Xuhong, primary, Lonigro, Robert J., primary, Vats, Pankaj, primary, Wang, Rui, primary, Lin, Su-Fang, primary, Cheng, Ann-Joy, primary, Kunju, Lakshmi P., primary, Siddiqui, Javed, primary, Tomlins, Scott A., primary, Wyngaard, Peter, primary, Sadis, Seth, primary, Roychowdhury, Sameek, primary, Hussain, Maha H., primary, Feng, Felix Y., primary, Zalupski, Mark M., primary, Talpaz, Moshe, primary, Pienta, Kenneth J., primary, Rhodes, Daniel R., primary, Robinson, Dan R., primary, and Chinnaiyan, Arul M., primary

Published
2023
Full Text
View/download PDF

26. Data from Identification of Targetable FGFR Gene Fusions in Diverse Cancers

Author

Wu, Yi-Mi, primary, Su, Fengyun, primary, Kalyana-Sundaram, Shanker, primary, Khazanov, Nickolay, primary, Ateeq, Bushra, primary, Cao, Xuhong, primary, Lonigro, Robert J., primary, Vats, Pankaj, primary, Wang, Rui, primary, Lin, Su-Fang, primary, Cheng, Ann-Joy, primary, Kunju, Lakshmi P., primary, Siddiqui, Javed, primary, Tomlins, Scott A., primary, Wyngaard, Peter, primary, Sadis, Seth, primary, Roychowdhury, Sameek, primary, Hussain, Maha H., primary, Feng, Felix Y., primary, Zalupski, Mark M., primary, Talpaz, Moshe, primary, Pienta, Kenneth J., primary, Rhodes, Daniel R., primary, Robinson, Dan R., primary, and Chinnaiyan, Arul M., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Figures from Identification of Targetable FGFR Gene Fusions in Diverse Cancers

Author

Wu, Yi-Mi, primary, Su, Fengyun, primary, Kalyana-Sundaram, Shanker, primary, Khazanov, Nickolay, primary, Ateeq, Bushra, primary, Cao, Xuhong, primary, Lonigro, Robert J., primary, Vats, Pankaj, primary, Wang, Rui, primary, Lin, Su-Fang, primary, Cheng, Ann-Joy, primary, Kunju, Lakshmi P., primary, Siddiqui, Javed, primary, Tomlins, Scott A., primary, Wyngaard, Peter, primary, Sadis, Seth, primary, Roychowdhury, Sameek, primary, Hussain, Maha H., primary, Feng, Felix Y., primary, Zalupski, Mark M., primary, Talpaz, Moshe, primary, Pienta, Kenneth J., primary, Rhodes, Daniel R., primary, Robinson, Dan R., primary, and Chinnaiyan, Arul M., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Figure 2 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Author

Berlin, Jordan, primary, Bendell, Johanna C., primary, Hart, Lowell L., primary, Firdaus, Irfan, primary, Gore, Ira, primary, Hermann, Robert C., primary, Mulcahy, Mary F., primary, Zalupski, Mark M., primary, Mackey, Howard M., primary, Yauch, Robert L., primary, Graham, Richard A., primary, Bray, Gordon L., primary, and Low, Jennifer A., primary

Published
2023
Full Text
View/download PDF

29. Supplementary Table 1 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Author

Berlin, Jordan, primary, Bendell, Johanna C., primary, Hart, Lowell L., primary, Firdaus, Irfan, primary, Gore, Ira, primary, Hermann, Robert C., primary, Mulcahy, Mary F., primary, Zalupski, Mark M., primary, Mackey, Howard M., primary, Yauch, Robert L., primary, Graham, Richard A., primary, Bray, Gordon L., primary, and Low, Jennifer A., primary

Published
2023
Full Text
View/download PDF

30. Supplementary Figure 5 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Author

Berlin, Jordan, primary, Bendell, Johanna C., primary, Hart, Lowell L., primary, Firdaus, Irfan, primary, Gore, Ira, primary, Hermann, Robert C., primary, Mulcahy, Mary F., primary, Zalupski, Mark M., primary, Mackey, Howard M., primary, Yauch, Robert L., primary, Graham, Richard A., primary, Bray, Gordon L., primary, and Low, Jennifer A., primary

Published
2023
Full Text
View/download PDF

31. Supplementary Table 1 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Author

Berlin, Jordan, primary, Bendell, Johanna C., primary, Hart, Lowell L., primary, Firdaus, Irfan, primary, Gore, Ira, primary, Hermann, Robert C., primary, Mulcahy, Mary F., primary, Zalupski, Mark M., primary, Mackey, Howard M., primary, Yauch, Robert L., primary, Graham, Richard A., primary, Bray, Gordon L., primary, and Low, Jennifer A., primary

Published
2023
Full Text
View/download PDF

32. Supplementary Figure 1 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Author

Berlin, Jordan, primary, Bendell, Johanna C., primary, Hart, Lowell L., primary, Firdaus, Irfan, primary, Gore, Ira, primary, Hermann, Robert C., primary, Mulcahy, Mary F., primary, Zalupski, Mark M., primary, Mackey, Howard M., primary, Yauch, Robert L., primary, Graham, Richard A., primary, Bray, Gordon L., primary, and Low, Jennifer A., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Table 1 from Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Author

Kim, Edward J., primary, Sahai, Vaibhav, primary, Abel, Ethan V., primary, Griffith, Kent A., primary, Greenson, Joel K., primary, Takebe, Naoko, primary, Khan, Gazala N., primary, Blau, John L., primary, Craig, Ronald, primary, Balis, Ulysses G., primary, Zalupski, Mark M., primary, and Simeone, Diane M., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Table 1 from Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Author

Kim, Edward J., primary, Sahai, Vaibhav, primary, Abel, Ethan V., primary, Griffith, Kent A., primary, Greenson, Joel K., primary, Takebe, Naoko, primary, Khan, Gazala N., primary, Blau, John L., primary, Craig, Ronald, primary, Balis, Ulysses G., primary, Zalupski, Mark M., primary, and Simeone, Diane M., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Figure 4 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Author

Berlin, Jordan, primary, Bendell, Johanna C., primary, Hart, Lowell L., primary, Firdaus, Irfan, primary, Gore, Ira, primary, Hermann, Robert C., primary, Mulcahy, Mary F., primary, Zalupski, Mark M., primary, Mackey, Howard M., primary, Yauch, Robert L., primary, Graham, Richard A., primary, Bray, Gordon L., primary, and Low, Jennifer A., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figure 5 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Author

Berlin, Jordan, primary, Bendell, Johanna C., primary, Hart, Lowell L., primary, Firdaus, Irfan, primary, Gore, Ira, primary, Hermann, Robert C., primary, Mulcahy, Mary F., primary, Zalupski, Mark M., primary, Mackey, Howard M., primary, Yauch, Robert L., primary, Graham, Richard A., primary, Bray, Gordon L., primary, and Low, Jennifer A., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Figure 4 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Author

Berlin, Jordan, primary, Bendell, Johanna C., primary, Hart, Lowell L., primary, Firdaus, Irfan, primary, Gore, Ira, primary, Hermann, Robert C., primary, Mulcahy, Mary F., primary, Zalupski, Mark M., primary, Mackey, Howard M., primary, Yauch, Robert L., primary, Graham, Richard A., primary, Bray, Gordon L., primary, and Low, Jennifer A., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure 1 Legend from Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Author

Kim, Edward J., primary, Sahai, Vaibhav, primary, Abel, Ethan V., primary, Griffith, Kent A., primary, Greenson, Joel K., primary, Takebe, Naoko, primary, Khan, Gazala N., primary, Blau, John L., primary, Craig, Ronald, primary, Balis, Ulysses G., primary, Zalupski, Mark M., primary, and Simeone, Diane M., primary

Published
2023
Full Text
View/download PDF

39. Supplementary Figure 1 from Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Author

Kim, Edward J., primary, Sahai, Vaibhav, primary, Abel, Ethan V., primary, Griffith, Kent A., primary, Greenson, Joel K., primary, Takebe, Naoko, primary, Khan, Gazala N., primary, Blau, John L., primary, Craig, Ronald, primary, Balis, Ulysses G., primary, Zalupski, Mark M., primary, and Simeone, Diane M., primary

Published
2023
Full Text
View/download PDF

40. Supplementary Figure 3 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Author

Berlin, Jordan, primary, Bendell, Johanna C., primary, Hart, Lowell L., primary, Firdaus, Irfan, primary, Gore, Ira, primary, Hermann, Robert C., primary, Mulcahy, Mary F., primary, Zalupski, Mark M., primary, Mackey, Howard M., primary, Yauch, Robert L., primary, Graham, Richard A., primary, Bray, Gordon L., primary, and Low, Jennifer A., primary

Published
2023
Full Text
View/download PDF

41. Supplementary Figure Legend from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Author

Berlin, Jordan, primary, Bendell, Johanna C., primary, Hart, Lowell L., primary, Firdaus, Irfan, primary, Gore, Ira, primary, Hermann, Robert C., primary, Mulcahy, Mary F., primary, Zalupski, Mark M., primary, Mackey, Howard M., primary, Yauch, Robert L., primary, Graham, Richard A., primary, Bray, Gordon L., primary, and Low, Jennifer A., primary

Published
2023
Full Text
View/download PDF

42. Supplementary Figure 3 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Author

Berlin, Jordan, primary, Bendell, Johanna C., primary, Hart, Lowell L., primary, Firdaus, Irfan, primary, Gore, Ira, primary, Hermann, Robert C., primary, Mulcahy, Mary F., primary, Zalupski, Mark M., primary, Mackey, Howard M., primary, Yauch, Robert L., primary, Graham, Richard A., primary, Bray, Gordon L., primary, and Low, Jennifer A., primary

Published
2023
Full Text
View/download PDF

43. Supplementary Figure 1 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Author

Berlin, Jordan, primary, Bendell, Johanna C., primary, Hart, Lowell L., primary, Firdaus, Irfan, primary, Gore, Ira, primary, Hermann, Robert C., primary, Mulcahy, Mary F., primary, Zalupski, Mark M., primary, Mackey, Howard M., primary, Yauch, Robert L., primary, Graham, Richard A., primary, Bray, Gordon L., primary, and Low, Jennifer A., primary

Published
2023
Full Text
View/download PDF

44. Supplementary Figure 2 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Author

Berlin, Jordan, primary, Bendell, Johanna C., primary, Hart, Lowell L., primary, Firdaus, Irfan, primary, Gore, Ira, primary, Hermann, Robert C., primary, Mulcahy, Mary F., primary, Zalupski, Mark M., primary, Mackey, Howard M., primary, Yauch, Robert L., primary, Graham, Richard A., primary, Bray, Gordon L., primary, and Low, Jennifer A., primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure Legend from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Author

Berlin, Jordan, primary, Bendell, Johanna C., primary, Hart, Lowell L., primary, Firdaus, Irfan, primary, Gore, Ira, primary, Hermann, Robert C., primary, Mulcahy, Mary F., primary, Zalupski, Mark M., primary, Mackey, Howard M., primary, Yauch, Robert L., primary, Graham, Richard A., primary, Bray, Gordon L., primary, and Low, Jennifer A., primary

Published
2023
Full Text
View/download PDF

47. Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

Author

Kunz, Pamela L., primary, Graham, Noah T., additional, Catalano, Paul J., additional, Nimeiri, Halla S., additional, Fisher, George A., additional, Longacre, Teri A., additional, Suarez, Carlos J., additional, Martin, Brock A., additional, Yao, James C., additional, Kulke, Matthew H., additional, Hendifar, Andrew E., additional, Shanks, James C., additional, Shah, Manisha H., additional, Zalupski, Mark M., additional, Schmulbach, Edmond L., additional, Reidy-Lagunes, Diane L., additional, Strosberg, Jonathan R., additional, O'Dwyer, Peter J., additional, and Benson, Al B., additional

Published
2022
Full Text
View/download PDF

48. Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials

Author

Ledenko, Matthew, primary, Antwi, Samuel O., additional, Arima, Shiho, additional, Driscoll, Julia, additional, Furuse, Junji, additional, Klümpen, Heinz-Josef, additional, Larsen, Finn Ole, additional, Lau, David K., additional, Maderer, Annett, additional, Markussen, Alice, additional, Moehler, Markus, additional, Nooijen, Lynn E., additional, Shaib, Walid L., additional, Tebbutt, Niall C., additional, André, Thierry, additional, Ueno, Makoto, additional, Woodford, Rachel, additional, Yoo, Changhoon, additional, Zalupski, Mark M., additional, and Patel, Tushar, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results